The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels

Y Yossef Maatuf (The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem) Y Yishai Kushnir (Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem) A Alina Nemirovski (Mass Spectrometry Unit, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem) M Mariana Ghantous (The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem) A Ariel Iskimov (The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem) A Alexander M. Binshtok (Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem) A Avi Priel (The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem)

Abstract

Paracetamol has been used for decades to relieve mild-to-moderate pain. Its analgesic effect is mainly attributed to its metabolite, AM404, acting on cannabinoid receptors or TRPV1 channels in central nervous system (CNS) neurons. Here, we show that AM404 is produced by primary sensory neurons. It inhibits sodium current in nociceptor neurons, blocking action potential (AP) generation and reducing nocifensive behavior in naïve and inflamed rats. We demonstrated that this analgesic effect of AM404 is mediated by its direct inhibition of nociceptive voltage-gated sodium channels (Na V ) 1.8 and 1.7 via the local anesthetic binding site. The Na V 1.8 and 1.7 inhibition was specific for AM404 and not observed with other metabolites of paracetamol. Our findings suggest that the analgesic effect of paracetamol is mediated mainly by direct AM404-induced inhibition of nociceptive sodium channels at the peripheral nociceptor neurons. Our findings lay a foundation for the potential development of AM404 as a selective local analgesic.

Article Details

Volume / Issue Vol. 122, Issue 23
Published June 10, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (7)

Y

Yossef Maatuf

The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem

Y

Yishai Kushnir

Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem

A

Alina Nemirovski

Mass Spectrometry Unit, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem

M

Mariana Ghantous

The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem

A

Ariel Iskimov

The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem

A

Alexander M. Binshtok

Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem

A

Avi Priel

The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem